No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

NCT04684368Phase 2Recruiting160 enrolled

View all 1 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Curative Treatment of Pediatric Hodgkin Lymphoma With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Consolidation Radiotherapy: A Systematic Review and Suggested Recommendations.

Hernández-Benítez Josué, López-Azcarraga Alejandra, Flerlage Jamie E et al. · JCO Glob Oncol · 2025

PMID: 40570263Meta-Analysis

Bleomycin for Malignant Pericardial Effusion: A Systematic Review of Efficacy and Adverse Events.

Siahaan Paulus Parholong, Kurniawan Roy Bagus, Saputra Pandit Bagus Tri et al. · J Cardiovasc Pharmacol · 2025

PMID: 40388305Meta-Analysis

Real-world effectiveness and safety of bleomycin in patients with keloids and hypertrophic scars: a systematic review and meta-analysis.

Wang Qimeng, Ren Zhesheng, Jin Wenyu et al. · Arch Dermatol Res · 2025

PMID: 39760851Meta-AnalysisFull text (PMC)

A systematic review of bleomycin-induced gonadotoxicity: Mechanistic implications for male reproductive health and fertility.

de Almeida Ana Lobo, Fortuna Ana, Sousa Mário et al. · Reprod Toxicol · 2024

PMID: 39326549Meta-Analysis

Skin and lung fibrosis induced by bleomycin in mice: a systematic review.

Gülle S, Çelik A, Birlik M et al. · Reumatismo · 2024

PMID: 38523580Meta-Analysis

The effect of concomitant use of Colony-Stimulating factors on bleomycin pulmonary toxicity - A systematic review and meta-analysis.

Mahdi Seyedzadeh Sani Seyed, Sahranavard Mehrdad, Jannati Yazdanabad Mahdi et al. · Int Immunopharmacol · 2022

PMID: 36099787Meta-Analysis

Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review.

Bastrup Freya A, Vissing Mille, Gehl Julie · Acta Oncol · 2022

PMID: 36036195Meta-Analysis

Bleomycin for Head and Neck Venolymphatic Malformations: A Systematic Review.

Finitsis Stephanos, Faiz Khunsa, Linton Janice et al. · Can J Neurol Sci · 2021

PMID: 32799947Meta-Analysis

Electrochemotherapy with bleomycin for basal cell carcinomas: a systematic review.

Hendel K, Jemec G B E, Haedersdal M et al. · J Eur Acad Dermatol Venereol · 2021

PMID: 34219303Meta-Analysis

Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.

Zhao Yunyu, Yan Zhipeng, Liu Ying et al. · Stem Cell Res Ther · 2021

PMID: 34420515Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Bleomycin (substance)
SNOMED CT: 372843005
UMLS CUI: C0005740
RxNorm CUI: 1622

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.